Yahoo Finance

Dr. Reddy’s (RDY) Laboratories announced that it is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL single-dose infusion bags to the consumer level, in the United States. The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.

Light Up your Portfolio with Spark:

• Easily identify stocks' risks and opportunities.

• Discover stocks' market position with detailed competitor analyses.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on RDY:

Questions or Comments about the article? Write to editor@tipranks.com

• Dr. Reddy’s Laboratories to Engage with Investors at Upcoming Conference

• Dr. Reddy’s Faces Tax Penalty, Evaluates Appeal

• Dr. Reddy’s Laboratories Receives Positive USFDA Inspection Outcome

• Dr. Reddy’s Allots Equity Shares Under Employee Stock Options

• Dr. Reddy’s Faces Tax Penalty from GST Authority